Skip to content

Effect of Aromatherapy on tiredness, insomnia and quality of life of patients with Breast and Gastrointestinal Cancer undergoing chemotherapy

Effect of Aromatherapy on fatigue, sleep quality and quality of life in patients with Breast and Gastrointestinal Cancer undergoing chemotherapy treatment: Randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6ynw9d6
Enrollment
Unknown
Registered
2025-01-22
Start date
2024-10-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, sleep quality, Breast Neoplasms, Digestive System Neoplasms

Interventions

Randomized, double-blind clinical trial, sample of 60 patients, with two arms, intervention group, 30 patients: blend of Lavender and Bergamot essential oils, control group, 30 patients: almond vegeta

Sponsors

Hospital de Clínicas da Universidade Federal do Paraná
Lead Sponsor
Universidade Federal do Paraná
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients of both sexes; diagnosed with Breast or Gastrointestinal Cancer; over 18 years of age; who will begin the chemotherapy protocol

Exclusion criteria

Exclusion criteria: Patients who use sleep inducers; with cognitive deficit; who already use aromatherapy or who are allergic to Lavender or Bergamot essential oil

Design outcomes

Primary

MeasureTime frame
It is expected to improve the fatigue of patients in the intervention group, using the essential oil blend, assessed using the Facit-Fatigue scale. Data will be collected on the first day before starting chemotherapy, 21, 42 and 63 days after the start of the intervention;It is expected to improve the quality of sleep of patients in the intervention group, assessed through the PSQI scale. Data will be collected on the first day before starting chemotherapy, 21, 42 and 63 days after the start of the intervention

Secondary

MeasureTime frame
It is expected to improve treatment coping. It can be assessed using the Fact-G Escape, which measures quality of life. Data will be collected on the first day before starting chemotherapy, 21, 42 and 63 days after the start of the intervention.

Countries

Brazil

Contacts

Public ContactAmanda Miranda

Hospital de Clínicas da Universidade Federal do Paraná

amanda.gomesmi@yahoo.com.br+55(41)995234226

Outcome results

None listed

Source: REBEC (via WHO ICTRP)